Newsfeed

Every published oncology item from an approved source, most recent first. No account required — this is the unfiltered stream, not personalized to any follows.

Items are tagged with the biomarkers and tumour types they resolve to; each tag opens that record, and every record’s page carries the same items back.

This demo serves a captured snapshot of the feed, not a live connection to the sources.

PubMed Central · Aug 10, 2026
DNA methylation signatures of sporadic colorectal cancer with microsatellite instability.
- colorectal cancer (tumour type)
Read at PubMed Central
PubMed Central · Aug 9, 2026
Invasive Breast Cancer Complicated by Colitis After TCbHP Chemotherapy: A Case Report.
- breast cancer (tumour type)
Read at PubMed Central
PubMed Central · Aug 9, 2026
Oxidative Stress-Associated Apoptotic Responses Induced by Lantana camara L. Flower-Derived Zinc Oxide Nanoparticles in Human Non-Small Cell Lung Cancer (NCI-H460) Cells.
- non-small cell lung cancer (tumour type)
Read at PubMed Central
PubMed Central · Aug 9, 2026
Integrative Analysis of Gene and Protein Expression Data Reveals Novel Clusters for Ovarian Cancer Prognosis.
- ovarian cancer (tumour type)
Read at PubMed Central
PubMed Central · Aug 7, 2026
Chronic interferon signaling at baseline is associated with acquired resistance to immunotherapy in metastatic melanoma.
- melanoma (tumour type)
Read at PubMed Central
PubMed Central · Aug 7, 2026
Colorectal cancer screening in individuals with multiple sclerosis: A mixed-methods study.
- colorectal cancer (tumour type)
Read at PubMed Central
U.S. Food and Drug Administration · Aug 6, 2026
FDA Approves New Engineered Viral Immunotherapy for Patients with Treatment-Resistant Advanced Melanoma
The U.S. Food and Drug Administration today granted accelerated approval to Tudriqev (vusolimogene oderparepvec-wtpg), a genetically modified oncolytic viral therapy for the treatment of advanced, refractory melanoma.
- melanoma (tumour type)
View original at U.S. Food and Drug Administration
PubMed Central · Aug 6, 2026
Biomarker-guided responses in patient-derived organoids predict effective therapies in breast cancer.
- breast cancer (tumour type)
Read at PubMed Central
PubMed Central · Aug 6, 2026
Precision neoadjuvant treatment with AI-assisted subtyping in HR+/HER2-breast cancer: A randomized, phase 2 trial FASCINATE-N.
- ERBB2 (biomarker)
- breast cancer (tumour type)
Read at PubMed Central
PubMed Central · Aug 6, 2026
Glutamine-restricted diets restore sensitivity to KRAS(G12D) inhibitor through the reversal of ANXA1 mediated metabolic reprogramming.
- KRAS (biomarker)
Read at PubMed Central
PubMed Central · Aug 4, 2026
Comprehensive Computed Tomography Evaluation of Gastric Cancer: 2026 Consensus Recommendation From the Korean Society of Abdominal Radiology.
- gastric cancer (tumour type)
Read at PubMed Central
PubMed Central · Jul 31, 2026
E3 Ubiquitin Ligase MDM2 Promotes Growth and CD8(+) T Cell Dysfunction in Gastric Cancer Through Degradation of SST.
- gastric cancer (tumour type)
Read at PubMed Central
PubMed Central · Jul 30, 2026
Distinct glycosyltransferase expression governs organ-specific survival in pancreatic cancer metastasis.
- pancreatic cancer (tumour type)
Read at PubMed Central
PubMed Central · Jul 30, 2026
YTHDF3 Promotes the Progression of Gastric Cancer by Activating the Wnt/β-Catenin Signaling Pathway via Targeting NEK7.
- gastric cancer (tumour type)
Read at PubMed Central
PubMed Central · Jul 30, 2026
Effect of exercise based prehabilitation on postoperative pain in breast cancer patients: a systematic review with meta-analysis.
- breast cancer (tumour type)
Read at PubMed Central
PubMed Central · Jul 29, 2026
Immunologic determinants of infusion products and the tumor microenvironment govern response to TIL therapy in advanced melanoma.
- melanoma (tumour type)
Read at PubMed Central
PubMed Central · Jul 29, 2026
An antibody-PROTAC conjugate targets BRD4/c-Myc/PD-L1 to enhance immunotherapy efficacy in triple-negative breast cancer.
- PD-L1 (biomarker)
- breast cancer (tumour type)
- triple-negative breast cancer (tumour type)
Read at PubMed Central
PubMed Central · Jul 29, 2026
DLL3-Targeted Strategies in Advanced Prostate Cancer: Current Evidence and Future Perspectives.
- prostate cancer (tumour type)
Read at PubMed Central
PubMed Central · Jul 29, 2026
Super enhancer-driven transcriptional reprogramming promotes abiraterone resistance via neuroendocrine transition and ferroptosis evasion in castration-resistant prostate cancer.
- prostate cancer (tumour type)
Read at PubMed Central
PubMed Central · Jul 28, 2026
Emerging Strategies Targeting the PI3K/AKT/mTOR Pathway in HR+/HER2- Advanced Breast Cancer.
- ERBB2 (biomarker)
- breast cancer (tumour type)
Read at PubMed Central

Newsfeed

DNA methylation signatures of sporadic colorectal cancer with microsatellite instability.

Invasive Breast Cancer Complicated by Colitis After TCbHP Chemotherapy: A Case Report.

Oxidative Stress-Associated Apoptotic Responses Induced by Lantana camara L. Flower-Derived Zinc Oxide Nanoparticles in Human Non-Small Cell Lung Cancer (NCI-H460) Cells.

Integrative Analysis of Gene and Protein Expression Data Reveals Novel Clusters for Ovarian Cancer Prognosis.

Chronic interferon signaling at baseline is associated with acquired resistance to immunotherapy in metastatic melanoma.

Colorectal cancer screening in individuals with multiple sclerosis: A mixed-methods study.

FDA Approves New Engineered Viral Immunotherapy for Patients with Treatment-Resistant Advanced Melanoma

Biomarker-guided responses in patient-derived organoids predict effective therapies in breast cancer.

Precision neoadjuvant treatment with AI-assisted subtyping in HR+/HER2-breast cancer: A randomized, phase 2 trial FASCINATE-N.

Glutamine-restricted diets restore sensitivity to KRAS(G12D) inhibitor through the reversal of ANXA1 mediated metabolic reprogramming.

Comprehensive Computed Tomography Evaluation of Gastric Cancer: 2026 Consensus Recommendation From the Korean Society of Abdominal Radiology.

E3 Ubiquitin Ligase MDM2 Promotes Growth and CD8(+) T Cell Dysfunction in Gastric Cancer Through Degradation of SST.

Distinct glycosyltransferase expression governs organ-specific survival in pancreatic cancer metastasis.

YTHDF3 Promotes the Progression of Gastric Cancer by Activating the Wnt/β-Catenin Signaling Pathway via Targeting NEK7.

Effect of exercise based prehabilitation on postoperative pain in breast cancer patients: a systematic review with meta-analysis.

Immunologic determinants of infusion products and the tumor microenvironment govern response to TIL therapy in advanced melanoma.

An antibody-PROTAC conjugate targets BRD4/c-Myc/PD-L1 to enhance immunotherapy efficacy in triple-negative breast cancer.

DLL3-Targeted Strategies in Advanced Prostate Cancer: Current Evidence and Future Perspectives.

Super enhancer-driven transcriptional reprogramming promotes abiraterone resistance via neuroendocrine transition and ferroptosis evasion in castration-resistant prostate cancer.

Emerging Strategies Targeting the PI3K/AKT/mTOR Pathway in HR+/HER2- Advanced Breast Cancer.